(1 - 11 von 11
)
aftonbladet.se: Falkar släpptes fria – tragedi direkt
Vi vet inte vad som hänt, säger Mats Grahn vid Stockholms ornitologiska förening. Tragedin inträffade redan under falkarnas första dag i frihet. De lite över en månad gamla fåglarna har fötts upp på Nordens ark och släpptes i fredags ut i Stockholm, där de fått ett eget bo på ett höghustak nära Skanstull på ...
Immunovia's CEO Mats Grahn sells 48,000 Immunovia shares to a Swedish...
news.cision.com
· The buyer is an institutional investor
· The transaction was carried out at a price of SEK
Immunovia, Pressconference, | Financial Hearings
financialhearings.com
Immunovia, Pressconference, December 20th :00 (Europe/Stockholm). Language: English. Speaker: CEO Mats Grahn. Sector: Health care ...
BIO Spring 2016: Immunovia's quest to make early-stage pancreatic...
www.biopharmadive.com
BioPharma
EU grants: Big changes this year in the SME-instrument - MVA
mva.org
Phone: (M) + Linkedin. Print Friendly, PDF & Email Print ... Mats Grahn, CEO at Immunovia which received 4,2 Million Euro for their Phase
Immunovia Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test
www.labiotech.eu
A blood test developed by Swedish-biotech Immunovia and scientists from Linköping University accurately diagnoses patients with rheumatoid arthritis even if...
Immunovia's IMMray Differentiates Lupus from Other Autoimmune...
lupusnewstoday.com
Read about Immunovia's IMMray that was seen to differentiate SLE from other autoimmune diseases with more than 90% accuracy.
Nasdaq Stockholm Welcomes Immunovia to the Main Market
view.news.eu.nasdaq.com
”The admission to trade on the main list of Nasdaq Stockholm is very positive as it strengthens the brand, increases the recognition of the company and confirms the progress and maturity of Immunovia,” said Mats Grahn, CEO and Chairman of the Board of Immunovia. “It is a result of Immunovia's progress ...
IMMray™ PanCan-d detects 98% of pancreatic cancers in retrospective...
www.diagnosticsworldnews.com
Mats Grahn, CEO Immunovia concluded: "We now have a strong confirmation that IMMray™ PanCan-d is able to detect pancreatic cancer in all stages, even in ...
Immunovia Sets Up U.S. Base to Commercialize Biomarker Test for Early...
www.genengnews.com
Molecular diagnostics firm Immunovia is setting up its U.S headquarters and CLIA-accredited reference laboratory in Boston, MA., in anticipation of the...
sortiert nach Relevanz / Datum